EX-10.1 3 d452677dex101.htm EX-10.1 SHARE PURCHASE AGREEMENT AND OMNIBUS AMENDMENTShare Purchase Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Share Purchase Agreement and Omnibus Amendment (this “Agreement”) is dated as of September 21, 2017, by and among Juno Therapeutics, Inc., a Delaware corporation (the “Company”), Celgene Corporation (“Celgene Corp.”), Celgene Switzerland LLC (“Celgene Switzerland”) and Celgene RIVOT Ltd (“Celgene RIVOT” and together with Celgene Corp. and Celgene Switzerland, the “Celgene Parties”).
SHARE PURCHASE AGREEMENT AND OMNIBUS AMENDMENTShare Purchase Agreement • September 22nd, 2017 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 22nd, 2017 Company Industry JurisdictionThis Share Purchase Agreement and Omnibus Amendment (this “Agreement”) is dated as of September 21, 2017, by and among Juno Therapeutics, Inc., a Delaware corporation (the “Company”), Celgene Corporation (“Celgene Corp.”), Celgene Switzerland LLC (“Celgene Switzerland”) and Celgene RIVOT Ltd (“Celgene RIVOT” and together with Celgene Corp. and Celgene Switzerland, the “Celgene Parties”).